Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STN1014100 ophthalmic solution in healthy volunteers and dry eye patients
jRCT2051220152Phase 1Completed
- Sponsor
- Santen Pharmaceutical
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of STN1014100 in dry eye syndrome (DED) (3 arms), sponsored by Santen Pharmaceutical. Primary endpoints: Safety, Pharmacokinetics and 1 more. Started Jan 2023; status: completed.
02
Drugs
STN1014100
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on jRCT2051220152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2051220152.